Kumari Shalini, Anand Raj, Sambyal Bhumika, Singh Yudhyavir, Rangappa Pradeep, Jha Simant Kumar
Ophthalmology, AlFalah School of Medical Sciences and Research Centre, Faridabad, Haryana, India.
Ophthalmology, Eye 7 Hospital, New Delhi, India.
J Family Med Prim Care. 2022 Sep;11(9):5041-5054. doi: 10.4103/jfmpc.jfmpc_747_22. Epub 2022 Oct 14.
The COVID-19 pandemic has led to the development and rollout of several vaccines worldwide at unprecedented pace. This systematic review of published literature has been undertaken to spread awareness among general physicians and ophthalmologists about the various reported adverse effects in the eye following COVID-19 vaccination. A systematic search was performed on 25 January 2022 through PuBMed, Medline and Google scholar for publications on ocular adverse effects after COVID-19 vaccination. One brief communication, four retrospective case series, sixteen case reports, and five letters to editors were included. Ocular manifestations most commonly appear in the uvea and retina. Other manifestations are seen on the eyelid, cornea and ocular surface, and in cranial nerves innervating the eye. The incidence rate of these manifestations is quite low after COVID-19 vaccinations. Our systematic review meticulously enumerates various adverse effects of COVID -19 vaccine on the eye. Most of these adverse effects are transient and observed to resolve without any sequelae except for cases of retinal and ophthalmic vascular occlusions and corneal graft rejections. An emphasis on close follow-up and a need to delay vaccination and modified therapy to control flare up of signs and symptoms in certain sub-populations, Graves' disease (autoimmune etiology), pre-existing uveal inflammation and corneal graft cases are warranted. We need long-term, larger, multicentric studies to substantiate our findings and establish the causal relationship with certainty. Mass vaccinations to curb this pandemic after outweighing the ocular risks associated with it is warranted.
新冠疫情促使全球以前所未有的速度研发并推出了多种疫苗。开展此次已发表文献的系统综述,旨在提高普通内科医生和眼科医生对新冠疫苗接种后眼部出现的各种不良反应的认识。2022年1月25日,通过PubMed、Medline和谷歌学术对关于新冠疫苗接种后眼部不良反应的出版物进行了系统检索。纳入了一篇简短通讯、四个回顾性病例系列、十六篇病例报告和五封给编辑的信。眼部表现最常见于葡萄膜和视网膜。其他表现见于眼睑、角膜和眼表,以及支配眼睛的颅神经。这些表现在新冠疫苗接种后的发生率相当低。我们的系统综述详细列举了新冠疫苗对眼睛的各种不良反应。除视网膜和眼部血管阻塞以及角膜移植排斥病例外,这些不良反应大多是短暂的,且观察到可自行缓解,无任何后遗症。对于某些亚人群,如格雷夫斯病(自身免疫病因)、既往存在的葡萄膜炎和角膜移植病例,强调密切随访以及在某些情况下需要推迟接种疫苗和调整治疗以控制体征和症状的发作是必要的。我们需要长期、更大规模、多中心的研究来证实我们的发现并确定因果关系。在权衡与疫苗相关的眼部风险后,进行大规模疫苗接种以遏制这一疫情是必要的。